DIRTT Announces Renewal of Normal Course Issuer Bid for Common Shares

DIRTT Announces Renewal of Normal Course Issuer Bid for Common Shares GlobeNewswire December 18, 2025 CALGARY, Alberta, Dec. 18, 2025 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (TSX: DRT; OTCQX: DRTTF) (“DIRTT” or the “Company”), a leader in industrialized construction, announced today that the Toronto Stock Exchange (“TSX”) has accepted DIRTT's notice of intention to […]

BigCommerce Partners with Stripe to Support New Agentic Commerce Suite and Empower Merchants to Sell Through AI Agents While Maintaining Security

BigCommerce Partners with Stripe to Support New Agentic Commerce Suite and Empower Merchants to Sell Through AI Agents While Maintaining Security New Stripe Agentic Commerce Suite integration will give BigCommerce merchants seamless access to AI-driven discovery, checkout and payments with minimal operational change GlobeNewswire December 18, 2025 AUSTIN, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) —

Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration

Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration The LOI Aligns with Federal Priorities on Fentanyl Crisis, Artificial Intelligence, and Quantum Technology GlobeNewswire December 18, 2025 ORLANDO, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) (“Nutriband”

Meredith & The Media Appoints Former Adweek Editor David Cohen; Launches Friday Media Lunch Series With Coffee Communications

Meredith & The Media Appoints Former Adweek Editor David Cohen; Launches Friday Media Lunch Series With Coffee Communications GlobeNewswire December 18, 2025 NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Meredith & The Media, a media publication focused on media industry news and exclusive interviews with journalists, today announced the appointment of former Adweek editor

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 WOBURN, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will present at the 44th Annual

Boast Launches First Tech-Enabled Solution Dedicated to Quebec’s CDAE-IA Program

Boast Launches First Tech-Enabled Solution Dedicated to Quebec's CDAE-IA Program Industry-leading R&D tax credit platform combines deep human expertise with AI-powered technology to navigate Quebec's historic shift toward AI innovation funding GlobeNewswire December 18, 2025 VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Boast, North America's leading R&D tax credit platform, today announced the

XWELL Expands Beyond Airports with New Wellness Retail Location in New York City’s Pennsylvania Station

XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station Bringing Accessible Self-Care to One of the Nation's Busiest Commuter Hubs GlobeNewswire December 18, 2025 NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the

SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award GlobeNewswire December 18, 2025 Two applicants will each receive a Grant of $50,000 to support the development of outstanding clinical cancer research to improve the treatment of NMIBC Applications for the fellowship are due on February 27, 2026 SCHAUMBURG,

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 BALA CYNWYD, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company's management team will present and

RESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026

RESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026 GlobeNewswire December 18, 2025 MIAMI, Dec. 18, 2025 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced its management team

Scroll to Top